Arvind Bagga Selected Research

Urea (Carbamide)

9/2012	Histomorphological classification of focal segmental glomerulosclerosis: a critical evaluation of clinical, histologic and morphometric features.
9/2008	Pyelonephritis presenting with severe acute renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arvind Bagga Research Topics

Disease

45	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2022 - 04/2002
14	Proteinuria 07/2021 - 04/2003
11	Atypical Hemolytic Uremic Syndrome 01/2022 - 10/2009
10	Infections 01/2019 - 04/2003
9	Rickets (Rachitis) 08/2022 - 04/2004
8	Hypertension (High Blood Pressure) 01/2021 - 10/2004
8	Glomerulonephritis 01/2021 - 04/2003
8	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2018 - 04/2003
7	Edema (Dropsy) 01/2022 - 08/2004
7	Hemolytic-Uremic Syndrome 01/2022 - 12/2010
6	Chronic Renal Insufficiency 10/2022 - 12/2010
6	Acute Kidney Injury (Acute Renal Failure) 07/2022 - 10/2007
6	Renal Insufficiency (Renal Failure) 01/2021 - 04/2005
6	Chronic Kidney Failure (Chronic Renal Failure) 12/2018 - 10/2008
6	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 03/2014 - 04/2003
5	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 08/2022 - 01/2005
5	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 04/2003
4	Hypophosphatemic Rickets 08/2022 - 01/2005
4	Dent Disease 08/2022 - 09/2009
4	Fanconi Syndrome (Syndrome, Fanconi) 08/2022 - 05/2018
4	Critical Illness (Critically Ill) 07/2022 - 07/2012
4	Hypokalemia 01/2021 - 09/2008
4	Hypophosphatemia 01/2019 - 01/2005
4	Thrombotic Microangiopathies 10/2014 - 12/2010
3	Acidosis 08/2022 - 07/2007
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021 - 01/2016
3	Hypercalciuria 09/2009 - 01/2005
2	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2020 - 03/2013
2	Nephrocalcinosis 01/2020 - 04/2005
2	Hypotension (Low Blood Pressure) 01/2019 - 08/2015
2	Dyslipidemias (Dyslipidemia) 12/2018 - 01/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 06/2018 - 02/2018
2	Night Blindness (Nyctalopia) 11/2016 - 09/2009
2	Polydipsia 11/2016 - 09/2009
2	Polyuria 11/2016 - 09/2009
2	Neoplasms (Cancer) 06/2014 - 10/2010
2	Hypercalcemia (Milk Alkali Syndrome) 12/2010 - 08/2008
2	Hyperphosphatemia 12/2010 - 04/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2008 - 01/2007
2	Systemic Vasculitis 10/2008 - 05/2005
1	Vitamin D Deficiency 08/2022
1	Thrombosis (Thrombus) 01/2022

Drug/Important Bio-Agent (IBA)

18	SteroidsIBA 12/2022 - 12/2003
13	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 04/2003
10	Rituximab (Mabthera)FDA Link 12/2022 - 01/2007
10	Vitamin D FDA LinkGeneric 10/2022 - 04/2004
10	Complement Factor H (Factor H)IBA 01/2022 - 10/2009
9	CreatinineIBA 04/2014 - 04/2005
8	AutoantibodiesIBA 01/2022 - 12/2010
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 05/2005
7	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 08/2004
7	Calcineurin InhibitorsIBA 07/2021 - 08/2012
6	Complement System Proteins (Complement)IBA 10/2019 - 12/2010
5	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 05/2009
5	SodiumIBA 01/2022 - 04/2008
5	Levamisole (Decaris)FDA Link 01/2019 - 12/2003
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 12/2003
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012 - 04/2003
4	AlbuminsIBA 01/2020 - 08/2004
4	Phosphates (Orthophosphate)IBA 01/2020 - 04/2004
3	Fibroblast Growth Factor-23IBA 10/2022 - 01/2019
3	DiureticsIBA 01/2022 - 04/2009
3	Serum AlbuminIBA 12/2018 - 04/2003
3	SaltsIBA 11/2016 - 08/2004
3	Parathyroid Hormone (Parathormone)IBA 08/2010 - 04/2004
3	Dexamethasone (Maxidex)FDA LinkGeneric 09/2008 - 04/2003
2	Cholecalciferol (Vitamin D3)FDA Link 10/2022 - 12/2010
2	ElectrolytesIBA 01/2022 - 08/2015
2	Tolvaptan FDA Link 01/2022 - 01/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 07/2011
2	Dichlorodiphenyldichloroethane (DDD)IBA 01/2021 - 05/2019
2	AcidsIBA 01/2020 - 07/2007
2	eculizumab FDA Link 10/2019 - 01/2013
2	LipidsIBA 12/2018 - 12/2010
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2016 - 03/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 05/2003
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2015 - 06/2014
2	AntibodiesIBA 10/2014 - 05/2014
2	Cystatin CIBA 04/2014 - 10/2007
2	Pentetic Acid (DTPA)FDA LinkGeneric 04/2014 - 10/2012
2	Enalapril FDA LinkGeneric 10/2013 - 01/2004
2	Valsartan (Vals)FDA Link 05/2013 - 08/2008
2	Urea (Carbamide)FDA LinkGeneric 09/2012 - 09/2008
2	Proteins (Proteins, Gene)FDA Link 08/2012 - 05/2009
2	MineralsIBA 12/2010 - 12/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2010 - 05/2009
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 04/2009 - 08/2004
2	Angiotensin Receptor AntagonistsIBA 08/2008 - 07/2005
2	Methylprednisolone FDA LinkGeneric 10/2004 - 04/2002
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 08/2022

Therapy/Procedure

38	Therapeutics 12/2022 - 04/2003
6	Plasma Exchange 10/2019 - 05/2014
3	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2022 - 02/2015
3	Continuous Renal Replacement Therapy 01/2020 - 08/2015
2	Catheters 10/2019 - 08/2015
2	Renal Dialysis (Hemodialysis) 01/2019 - 02/2015
2	Kidney Transplantation 12/2018 - 11/2010
2	Duration of Therapy 01/2017 - 01/2015
2	Peritoneal Dialysis 02/2015 - 10/2009
1	Hybrid Renal Replacement Therapy 07/2022